Childhood Onset Strabismus: A Neurotrophic Factor Hypothesis.

Neurotrophic factor extraocular muscles glial derived neurotrophic factor insulin-like growth factor strabismus

Journal

Journal of binocular vision and ocular motility
ISSN: 2576-1218
Titre abrégé: J Binocul Vis Ocul Motil
Pays: United States
ID NLM: 101730067

Informations de publication

Date de publication:
Historique:
pubmed: 20 4 2021
medline: 29 10 2021
entrez: 19 4 2021
Statut: ppublish

Résumé

Strabismus is a genetically heterogeneous disorder with complex molecular and neurophysiological causes. Evidence in the literature suggests a strong role for motor innervation in the etiology of strabismus, which connects central neural processes to the peripheral extraocular muscles. Current treatments of strabismus through surgery show that an inherent sensorimotor plasticity in the ocular motor system decreases the effectiveness of treatment, often driving eye alignment back toward its misaligned pre-surgical state by altering extraocular muscle tonus. There is recent interest in capitalizing on existing biological processes in extraocular muscles to overcome these compensatory mechanisms. Neurotrophins are trophic factors that regulate survival and development in neurons and muscle, including extraocular muscles. Local administration of neurotrophins to extraocular muscles partially reversed strabismus in an animal model of strabismus. The hypothesis is that sustained release of neurotrophins gives more time for the ocular motor system to adapt to a slow change in alignment in the desired direction. The effect of neurotrophins on extraocular muscles is complex, as different neurotrophic factors have diverse effects on extraocular muscle contraction profiles, patterns of innervation, and density of extraocular muscle precursor cells. Neurotrophic factors show promise as a therapeutic option for strabismus, which may help to improve treatment outcomes and offset devastating amblyopia and psychosocial effects of disease in strabismus patients.

Identifiants

pubmed: 33872122
doi: 10.1080/2576117X.2021.1893585
pmc: PMC8102408
mid: NIHMS1679226
doi:

Substances chimiques

Nerve Growth Factors 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

35-40

Subventions

Organisme : NEI NIH HHS
ID : P30 EY011374
Pays : United States
Organisme : NEI NIH HHS
ID : R01 EY006069
Pays : United States
Organisme : NEI NIH HHS
ID : R01 EY015313
Pays : United States

Références

Invest Ophthalmol Vis Sci. 2018 Oct 1;59(12):5011-5021
pubmed: 30326068
Invest Ophthalmol Vis Sci. 2014 Nov 20;56(1):10-9
pubmed: 25414191
Invest Ophthalmol Vis Sci. 2007 Feb;48(2):665-74
pubmed: 17251464
Invest Ophthalmol Vis Sci. 2016 Nov 1;57(14):6070-6078
pubmed: 27820875
Growth Horm IGF Res. 2011 Aug;21(4):228-32
pubmed: 21703892
Invest Ophthalmol Vis Sci. 2015 Jun;56(6):3484-96
pubmed: 26030103
Mol Cell Neurosci. 2002 Jan;19(1):58-71
pubmed: 11817898
Neuron. 1997 Mar;18(3):411-23
pubmed: 9115735
PLoS One. 2014 Oct 15;9(10):e109833
pubmed: 25334047
Nat Genet. 2003 Dec;35(4):318-21
pubmed: 14595441
Annu Rev Neurosci. 2001;24:677-736
pubmed: 11520916
J Pediatr Ophthalmol Strabismus. 2016 Sep 1;53(5):305-10
pubmed: 27486726
Invest Ophthalmol Vis Sci. 2006 Feb;47(2):605-13
pubmed: 16431957
Invest Ophthalmol Vis Sci. 2008 Jan;49(1):215-20
pubmed: 18172095
Cells. 2020 Mar 18;9(3):
pubmed: 32197508
Arch Ophthalmol. 2007 Feb;125(2):189-95
pubmed: 17296894
Invest Ophthalmol Vis Sci. 2016 Jun 1;57(7):3168-80
pubmed: 27309621
Invest Ophthalmol Vis Sci. 1995 Nov;36(12):2547-50
pubmed: 7591645
Science. 2008 Aug 8;321(5890):839-43
pubmed: 18653847
Invest Ophthalmol Vis Sci. 2004 Oct;45(10):3538-45
pubmed: 15452060
Invest Ophthalmol Vis Sci. 2016 Oct 1;57(13):5576-5585
pubmed: 27768799
J AAPOS. 2009 Feb;13(1):8-12
pubmed: 18993096
J AAPOS. 2018 Oct;22(5):356-360
pubmed: 30217512
J AAPOS. 2020 Oct;24(5):285.e1-285.e6
pubmed: 32950611
Mol Cell Neurosci. 2003 Sep;24(1):41-56
pubmed: 14550767
Invest Ophthalmol Vis Sci. 2011 Aug 24;52(9):6697-705
pubmed: 21743010
Invest Ophthalmol Vis Sci. 2015 Jun;56(6):3467-83
pubmed: 26030102
Invest Ophthalmol Vis Sci. 2008 Jan;49(1):221-9
pubmed: 18172096
Invest Ophthalmol Vis Sci. 2006 Jun;47(6):2461-7
pubmed: 16723457
Invest Ophthalmol Vis Sci. 2010 May;51(5):2479-86
pubmed: 20007833
J Neurosci. 2010 Jun 16;30(24):8308-19
pubmed: 20554882
Ophthalmic Surg Lasers Imaging. 2006 Mar-Apr;37(2):129-37
pubmed: 16583634
J AAPOS. 2006 Oct;10(5):424-9
pubmed: 17070477
Curr Ophthalmol Rep. 2017 Sep;5(3):207-215
pubmed: 29109908
Invest Ophthalmol Vis Sci. 2010 Nov;51(11):5646-56
pubmed: 20538996
J Neurophysiol. 2017 Mar 1;117(3):1281-1292
pubmed: 28031397
Invest Ophthalmol Vis Sci. 2016 Dec 1;57(15):6831-6842
pubmed: 28002846
J Neurophysiol. 2015 Aug;114(2):857-68
pubmed: 26063778
J Neurosci. 2009 Jan 14;29(2):575-87
pubmed: 19144857
Invest Ophthalmol Vis Sci. 2011 Jun 08;52(7):4021-9
pubmed: 21357389
Hum Mol Genet. 2017 Aug 1;26(R1):R37-R44
pubmed: 28459979
Invest Ophthalmol Vis Sci. 2012 Jun 22;53(7):3858-64
pubmed: 22562519
Invest Ophthalmol Vis Sci. 2019 Oct 1;60(13):4292-4302
pubmed: 31618766
Invest Ophthalmol Vis Sci. 1980 Jul;19(7):841-5
pubmed: 6771223
Trans Am Ophthalmol Soc. 1981;79:734-70
pubmed: 7043872
Invest Ophthalmol Vis Sci. 2006 Aug;47(8):3360-5
pubmed: 16877403
Pediatr Clin North Am. 2014 Jun;61(3):505-18
pubmed: 24852148
Muscle Nerve. 2004 May;29(5):707-15
pubmed: 15116375
Invest Ophthalmol Vis Sci. 2016 Nov 1;57(14):6040-6047
pubmed: 27820877
Pflugers Arch. 2011 Mar;461(3):373-86
pubmed: 21279379
Invest Ophthalmol Vis Sci. 2012 Aug 03;53(9):5168-77
pubmed: 22786898
Sci Rep. 2020 Jul 17;10(1):11927
pubmed: 32681083
Development. 2010 Apr;137(7):1205-13
pubmed: 20215354
In Vitro Cell Dev Biol Anim. 2017 Mar;53(3):265-271
pubmed: 27800570
Strabismus. 2019 Jun;27(2):54-65
pubmed: 31012389
Sci Rep. 2016 May 16;6:25960
pubmed: 27180807
J Neurophysiol. 2017 Jul 1;118(1):280-299
pubmed: 28404829
J AAPOS. 2010 Aug;14(4):298-304
pubmed: 20736121
Ophthalmology. 2009 Nov;116(11):2128-34.e1-2
pubmed: 19762084
Ann N Y Acad Sci. 2002 Apr;956:346-60
pubmed: 11960818
Invest Ophthalmol Vis Sci. 2003 Sep;44(9):3866-72
pubmed: 12939302
Proc Natl Acad Sci U S A. 2012 Sep 4;109(36):14669-74
pubmed: 22912401
Invest Ophthalmol Vis Sci. 2014 Jan 13;55(1):265-74
pubmed: 24204052
Invest Ophthalmol Vis Sci. 2020 Apr 9;61(4):8
pubmed: 32282917
J Neurobiol. 1999 Nov 5;41(2):295-315
pubmed: 10512985

Auteurs

Jolene C Rudell (JC)

Department of Ophthalmology, University California San Diego, San Diego, California.

Jérome Fleuriet (J)

Assistance Publique-Hôpitaux de Paris, Intensive Care Unit, Raymond Poincaré Hospital, Garches, France.

Michael J Mustari (MJ)

Washington National Primate Research Center, University of Washington, Seattle, Washington.
Department of Ophthalmology, University of Washington, Seattle, Washington.

Linda K McLoon (LK)

Department of Ophthalmology and Visual Neurosciences, University of Minnesota, Minneapolis, Minnesota.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH